Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Debra, Fayter"'
Autor:
Marie Westwood, Bram Ramaekers, Sabine Grimm, Gill Worthy, Debra Fayter, Nigel Armstrong, Titas Buksnys, Janine Ross, Manuela Joore, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 25, Iss 33 (2021)
Background: Early diagnosis of acute myocardial infarction is important, but only 20% of emergency admissions for chest pain will actually have an acute myocardial infarction. High-sensitivity cardiac troponin assays may allow rapid rule out of myoca
Externí odkaz:
https://doaj.org/article/fd1acba4d09b469eb9f565adbc34bcb0
Autor:
Ben Wijnen, Willem Witlox, Robert Wolff, Debra Fayter, Bram Ramaekers, Thomas Otten, Steve Ryder, Pawel Posadzki, Gill Worthy, Lisa Stirk, Nigel Armstrong, Jos Kleijnen, Manuela Joore
Publikováno v:
PharmacoEconomics.
Fenfluramine, tradename Fintepla ®, was appraised within the National Institute for Health and Care Excellence (NICE) single technology appraisal (STA) process as Technology Appraisal 808. Within the STA process, the company (Zogenix International)
Autor:
Joanne O’Connor, Dorothy McCaughan, Catriona McDaid, Alison Booth, Debra Fayter, Roccio Rodriguez-Lopez, Roy Bowers, Lisa Dyson, Cynthia P Iglesias, Simon Lalor, Rory J O’Connor, Margaret Phillips, Gita Ramdharry
Publikováno v:
Health Technology Assessment, Vol 20, Iss 55 (2016)
Background: Patients who have knee instability that is associated with neuromuscular disease (NMD) and central nervous system (CNS) conditions can be treated using orthoses, such as knee–ankle–foot orthoses (KAFOs). Objectives: To assess existing
Externí odkaz:
https://doaj.org/article/112d1d61fcb7421391bc6a9412268d4f
Autor:
Nigel Armstrong, Sabine Grimm, Debra Fayter, Bram Ramaekers, Janine Ross, Titas Buksnys, Richard Body, Adam Timmis, Paul Collinson, Marie Westwood, Gill Worthy, Jos Kleijnen, Nicholas L. Mills
Publikováno v:
Clinical Chemistry. 67:237-244
Background We assessed the accuracy and clinical effectiveness of high-sensitivity cardiac troponin (hs-cTn) assays for early rule-out of non-ST-segment elevation myocardial infarction (NSTEMI) in adults presenting with acute chest pain. Methods Sixt
Autor:
Marie Westwood, Willem J.A. Witlox, Debra Fayter, Ben F. M. Wijnen, Kate Misso, Steve Ryder, Titas Buksnys, Nigel Armstrong, Gill Worthy, Bram Ramaekers, Manuela A. Joore, Sabine Grimm, Jos Kleijnen
Publikováno v:
Pharmacoeconomics. 38(10):1043-1053
GW Research Ltd. provided two separate, but similar, submissions to the National Institute for Health and Care Excellence (NICE) on the clinical and cost-effectiveness of cannabidiol (CBD) 10 mg/kg/day, trade name Epidyolex(R), for the adjunctive tre
Autor:
Debra Fayter, Nasuh Büyükkaramikli, Kate Misso, Frederick W. Thielen, Ching-Yun Wei, Gill Worthy, Isaac Corro Ramos, Rob Riemsma, Nigel Armstrong, Jos Kleijnen, Vanesa Huertas Carrera
Publikováno v:
Pharmacoeconomics. 37(8):975-984
The National Institute for Health and Care Excellence (NICE), as part of the institute’s single technology appraisal (STA) process, invited the company that makes obinutuzumab (Roche Products Limited) to submit evidence of the clinical and cost eff
Autor:
Jos Kleijnen, Nigel Armstrong, Gill Worthy, Bram Ramaekers, Debra Fayter, Sohan Deshpande, Xavier Pouwels, Rob Riemsma, Steven Duffy, Manuela A. Joore, Sabine Grimm, Willem J.A. Witlox
Publikováno v:
Pharmacoeconomics
The National Institute for Health and Care Excellence (NICE) invited Teva, the company manufacturing arsenic trioxide (ATO; tradename Trisenox((R))), to submit evidence for the clinical and cost effectiveness of ATO for untreated and relapsed or refr
Publikováno v:
Cancer Management and Research. 11:2321-2337
Purpose To conduct a systematic review of international guidelines on screening and management of patients with BRCA-mutated breast cancer (BC). Methods Major electronic databases (MEDLINE and Embase; N=8) and gray literature sources were searched (J
Autor:
Ben, Wijnen, Nigel, Armstrong, Bram, Ramaekers, Willem, Witlox, Marie, Westwood, Debra, Fayter, Steve, Ryder, Titas, Buksnys, Gill, Worthy, Kate, Misso, Sabine, Grimm, Jos, Kleijnen, Manuela, Joore
Publikováno v:
PharmacoEconomics. 38(10)
GW Research Ltd. provided two separate, but similar, submissions to the National Institute for Health and Care Excellence (NICE) on the clinical and cost-effectiveness of cannabidiol (CBD) 10 mg/kg/day, trade name Epidyolex
Publikováno v:
Cancer Management and Research
Purpose To conduct a systematic review of international guidelines on screening and management of patients with BRCA-mutated breast cancer (BC). Methods Major electronic databases (MEDLINE and Embase; N=8) and gray literature sources were searched (J